coteau ARQ.

BSEM

BioStem Technologies, Inc.
$1.57
−$0.09 (5.42%) Oct 23 close
Healthcare CompareTechnicals
1M3M6M1Y2Y
-70%-35%+1%+36%+72%Oct 2025Oct 2026Apr 202652w high $8.4052w low $1.45
BSEMSPY
Wall St. Highest PT $7.00 (+345.9%) Wall St. Avg PT $7.00 (+345.9%)
$2$4$6$8$10POC $4Hi $7Avg $7
Underwater Drawdown %Max DD -81.2%Current -80.9%
0.0%-81.2%
Relative Strength vs SPY-82.9% vs SPYUnderperforming
+97%0%-97%
1W
−$0.52 (24.88%)
1M
−$2.23 (58.68%)
3M
−$2.44 (60.85%)
6M
−$3.26 (67.49%)
YTD
−$2.24 (58.79%)
1Y
−$3.28 (67.66%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Analyst price targets
Current price$1.57
Average target$7.00
+$5.43 (+345.9%) upsideaverage target vs current price
12-month Wall Street target range
Recent analyst rating changes · 1
Initiated
2022-11-07 · Zacks Investment Research started covering BSEM at Buy
All analyst rating changes ›

Third-party ratings, not Coteau's views.

Key stats & company

Market value$29.3M
P/E (last 12 months)1.8
P/E (next 12 months, estimated)5.4
52-week range$1.45 – $8.40
Revenue growth (latest quarter vs a year ago)-27.9%
Dividend yieldNo dividend
Average analyst price target$7.00 (+346%)

What they do

BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a human connective tissue matrix compromised of amniotic tissue intended for wound covering. BioStem Technologies, Inc. was incorporated in 2006 and is based in Fort Lauderdale, Florida.

Healthcare · Biotechnology
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

No sector grades for BSEM yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
Outside this model's universe or screens
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 Coteau Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 Coteau Physical AI Grid & Power
Outside this model's universe or screens
 Coteau Long Book
Not in the current book

Earnings & events

BSEM earningsNext report in 19 days
Next report
Thu Nov 12, 2026Time not confirmed
EPS consensus$0.10
Revenue consensus$7.2M 1 analysts
Last 4 quarters · EPS vs estimate
Aug 12, 2026-$0.52est -$0.50−4.0%Below estimates
May 14, 2026-$0.52est -$0.28−85.7%Below estimates
Nov 13, 2025$0.06est ––
Aug 13, 2025$0.11est $0.32−66.9%Below estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · refreshed 2026-10-24 02:37:39 ET
24-0824-1125-0425-0525-0825-1126-0526-08-0.521.25
EstimateActual (beat)Actual (miss)

Quarterly revenue

QuarterRevenueYoY
2026-06-30$7.9M–
2025-09-30$10.5M–
2025-06-30$11.0M–

News & catalysts

More news
BioStem Technologies’ CEO and COO Invest $1 Million in Cash Through Exercise of Stock Options
GlobeNewswire · Oct 08
BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio
GlobeNewswire · Oct 01
BioStem Technologies Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules
GlobeNewswire · Sep 30
Terminal1, the operating system built for public companies, announced today that BioStem Technologies, Inc. (NASDAQ: BSEM) has joined the Terminal1 platform
GlobeNewswire · Sep 21
BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility
GlobeNewswire · Sep 18
Rating changes
Initiated
2022-11-07 · Zacks Investment Research started covering BSEM at Buy

Third-party analyst actions, not Coteau's views. All rating changes

Stats refreshed 2026-10-24 02:37:39 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, Coteau model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

coteau

Free to use. No card, no ads, no auto-renew.

Independent research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026